Arthur Krieg was Promoted as Founder and Chief Scientific Officer at Checkmate Pharmaceuticals

Date of management change: December 15, 2018 

What Happened?

Cambridge, MA-based Checkmate Pharmaceuticals Promoted Arthur Krieg as Founder and Chief Scientific Officer


About the Company

It has exclusively licensed a clinically validated virus-like particle (VLP) platform from Cytos Biotechnology Ltd (SIX:CYTN) for the field of oncology, that includes the clinical product (CYT003) and technologies related to oligonucleotide synthesis and VLP delivery. CYT003 is a product derived from the CpG class of oligonucleotides that activates the immune system via Toll-like receptor 9 (TLR9) and has the potential to improve efficacy outcomes and broaden the size of the populations that can benefit from checkpoint inhibitor therapies.


About the Person

Arthur M. Krieg is Founder and Chief Scientific Officer at Checkmate Pharmaceuticals. Previously, Arthur held various senior HR leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Estacion Carlene, Leese Robyn, Cobb Elizabeth, Copeland Sue, Smith Lauren, Flores Greg, Cassidy Kari, Hodge Kathryn, Thomas Mary, Fox Janice, Modafferi Joanne

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.